Semaglutide (#wegovy\#ozempic) was shown to reduce risk of heart attack, strokes & death in those with obesity and heart disease but this analysis confirms that the #weightloss, per se, is not the Novo Nordisk's Ozempic pill, the only FDA approved oral peptide GLP 1 medication for adults with type 2 diabetes, soon to be available in the US The rise in weight loss drugs like Ozempic means food producers worldwide are assessing their future with more buyers consuming less and placing more focus on wellness and health. For Ireland's 18bn dairy Who Can Prescribe Semaglutide? Prescribers and Online Options Ro, Eli Lilly strike deal to offer lower price vials of Zepbound